Safety, Tolerance, and Pharmacokinetics of Single Oral Doses of BI 201335 NA and Bioavailability in Healthy Male Subjects
Clinical trial NCT02182323 · COMPLETED
Trial details
- NCT number
- NCT02182323
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-09-01
- Primary completion
- 2006-12-01
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.